This study tested an experimental medication to see if it could reduce fatigue and other symptoms in adults with long COVID. About 400 participants who had persistent symptoms for over 12 weeks after a COVID-19 infection took either the drug or a placebo. The goal was to improve …
Phase: PHASE3 • Sponsor: Cardresearch • Aim: Symptom relief
Last updated May 06, 2026 10:04 UTC